COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #108
Source   PDF   Share   Tweet
See all 182 studies
Late treatment study
Gonzalez et al., medRxiv, doi:10.1101/2020.08.18.20172874 (Preprint)
The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals
Retrospective study focused on eosinophil recovery with 9,644 hospitalized patients in Spain, showing lower mortality for HC Q (14.7% vs 29.2%, p<0.001), and AZ (15.3% vs. 18.4%, p<0.001). With a multivariate model including potential confounding factors, HC Q and AZ are associated with lower mortality, HC Q OR 0.662, p=0.057.
death, ↓26.6%, p=0.06
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 182 studies
Please send us corrections, updates, or comments.